Jari Tiihonen, MD, PhD, Professor

  • 5Articles
  • 20.8KReads
  • 1999–2024Active
  • 28Collaborators
  • 34Citations

About

Jari Tiihonen, MD, PhD, Professor, is affiliated with the Department of Forensic Psychiatry at the University of Eastern Finland and Niuvanniemi Hospital, as well as with institutions in Sweden and Finland including the Karolinska Institutet and the University of Helsinki. Tiihonen has published extensively on topics such as schizophrenia and schizoaffective disorders, Alzheimer disease, neuroleptic malignant syndrome, and neurology. His work includes studies on antipsychotic medication risks, treatment-resistant schizophrenia, and drug interactions affecting cardiac function. Tiihonen has contributed to Psychiatrist.com from 1999 through 2024.

Publications

JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
, , , et al
PCC
Case Report

Valproate and Neuroleptic Malignant Syndrome

June 11, 2020

Neuroleptic malignant syndrome (NMS) is often associated with use of typical antipsychotics, but antiepileptics have also been implicated. This report describes the case of an elderly man with schizophrenia...
, ,
JCP
Original Research

Antipsychotics and Risk of Hip Fractures

March 29, 2017

Antipsychotics  are frequently used to treat symptoms of Alzheimer's disease, but does this treatment increase the risk of hip fracture in these patients? Read this cohort study to learn...
, , , et al
JCP
Original Research

Topiramate Add-On in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

August 15, 2005

, , , et al
JCP
Letter to the Editor

Transient Syncope and ECG Changes Associated With the Concurrent Administration of Clozapine and Diazepam

September 30, 1999

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe